AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 6 2005-R2012, Copyright © 1997 by American Physiological Society

ARTICLES

Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans

L. Schmetterer, O. Findl, K. Strenn, U. Graselli, J. Kastner, H. G. Eichler and M. Wolzt
Department of Clinical Pharmacology, Vienna University, Austria.

It is well known that changes in PCO2 or PO2 strongly influence cerebral and ocular blood flow. However, the mediators of these changes have not yet been completely identified. There is evidence from animal studies that NO may play a role in hypercapnia-induced vasodilation and that NO synthase inhibition modulates the response to hyperoxia in the choroid. Hence we have studied the effect of NO synthase inhibition by NG-monomethyl-L-arginine (L-NMMA, 3 mg/kg over 5 min as a bolus followed by a continuous infusion of 30 micrograms.kg-1.min-1) on the changes of cerebral and ocular hemodynamic parameters elicited by hypercapnia and hyperoxia in healthy young subjects. Mean flow velocities in the middle cerebral artery and the ophthalmic artery were measured with Doppler ultrasound, and ocular fundus pulsation amplitude, which estimates pulsatile choroidal blood flow, was measured with laser interferometry Administration of L-NMMA reduced ocular fundus pulsation. (-19%, P < 0.005) but only slightly reduced mean flow velocities in the larger arteries. Hypercapnia (PCO2 = 48 mmHg) significantly increased mean flow velocities in the middle cerebral artery (+26%, P < 0.01) and fundus pulsation amplitude (+16%, P < 0.005) but did not change mean flow velocity in the ophthalmic artery. The response to hypercapnia in the middle cerebral artery (P < 0.05) and in the choroid (P < 0.05) was significantly blunted by L-NMMA. On the contrary, L-NMMA did not affect hyperoxia-induced (PO2 = 530 mmHg) hemodynamic changes. The hemodynamic effects of L-NMMA (at baseline and during hypercapnia) were reversed by coadministration of L-arginine. The present study supports the concept that NO has a role in hypercapnia induced vasodilation in humans.

This article has been cited by other articles:

				K. Ide, M. Worthley, T. Anderson, and M. J. Poulin Effects of the nitric oxide synthase inhibitor L-NMMA on cerebrovascular and cardiovascular responses to hypoxia and hypercapnia in humans J. Physiol., October 1, 2007; 584(1): 321 - 332. [Abstract] [Full Text] [PDF]

				R. Zhang, T. E. Wilson, S. Witkowski, J. Cui, C. G. Crandall, and B. D. Levine Inhibition of nitric oxide synthase does not alter dynamic cerebral autoregulation in humans Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H863 - H869. [Abstract] [Full Text] [PDF]

				G. T. Dorner, G. Garhofer, B. Kiss, E. Polska, K. Polak, C. E. Riva, and L. Schmetterer Nitric oxide regulates retinal vascular tone in humans Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H631 - H636. [Abstract] [Full Text] [PDF]

				S. R. Thom, D. Fisher, J. Zhang, V. M. Bhopale, S. T. Ohnishi, Y. Kotake, T. Ohnishi, and D. G. Buerk Stimulation of perivascular nitric oxide synthesis by oxygen Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1230 - H1239. [Abstract] [Full Text] [PDF]

				D. Checchin, X. Hou, P. Hardy, D. Abran, T. Najarian, M. H. Beauchamp, S. G. Bernier, F. Gobeil Jr, C. Quiniou, D. R. Varma, et al. PGE2-Mediated eNOS Induction in Prolonged Hypercapnia Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1558 - 1566. [Abstract] [Full Text] [PDF]

				K. Polak, G. Dorner, B. Kiss, E. Polska, O. Findl, G. Rainer, H.-G. Eichler, and L. Schmetterer Evaluation of the Zeiss retinal vessel analyser Br. J. Ophthalmol., November 1, 2000; 84(11): 1285 - 1290. [Abstract] [Full Text] [PDF]

				A. Luksch, K. Polak, C. Beier, E. Polska, M. Wolzt, G. T. Dorner, H.-G. Eichler, and L. Schmetterer Effects of Systemic NO Synthase Inhibition on Choroidal and Optic Nerve Head Blood Flow in Healthy Subjects Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3080 - 3084. [Abstract] [Full Text]

				M. Bayerle-Eder, M. Wolzt, E. Polska, H. Langenberger, J. Pleiner, D. Teherani, G. Rainer, K. Polak, H.-G. Eichler, and L. Schmetterer Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1667 - R1673. [Abstract] [Full Text] [PDF]

				B. Kiss, S. Dallinger, O. Findl, G. Rainer, H.-G. Eichler, and L. Schmetterer Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1661 - R1667. [Abstract] [Full Text] [PDF]